Europe Pharmaceutical Filtration Market worth $5.95 billion by 2030
The report "Europe Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030" is projected to grow from USD 4.05 billion in 2025 and to reach USD 5.95 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period.
Browse 200 market data Tables and 53 Figures spread through 250 Pages and in-depth TOC on "Europe Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-pharmaceutical-filtration-market-115776969.html
The pharmaceutical filtration market is experiencing growth, driven by several key factors, including increased demand for high-efficiency, regulatory-compliant filtration systems that ensure sterility.
The microfiltration segment accounted for the largest share of the Europe pharmaceutical filtration market, by technique, in 2024.
By?????? technique, the Europe pharmaceutical filtration market is split into microfiltration, ultrafiltration, nanofiltration, and other techniques. Due to its extensive use for sterile venting, buffer and media clarification, and protection of downstream chromatography columns, the microfiltration segment has emerged as the leading segment in biologics and small-molecule manufacturing. Microfiltration is especially suitable for high cell-density cultures and shear-sensitive products, where gentle clarification is required to maintain product integrity and increase yield. In numerous manufacturing plants across Europe, microfiltration is also the technology that supports single-use bioreactor and disposable manifold designs, thus becoming a backbone of flexible, multi-product manufacturing.
The final product processing segment is expected to be the fastest-growing segment in the Europe pharmaceutical filtration market, by application, during the forecast period.
By application, the Europe pharmaceutical filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing encompasses API filtration, protein and vaccine purification, formulation and filling solutions, and viral clearance at the finished drug stage. In Europe, this application area is rapidly developing and becoming the most significant one, as the EMA and national regulators are becoming increasingly stringent regarding viral safety standards for injectable biologics and advanced therapies. Manufacturers are upgrading their production lines with high-performance, sterilizing-grade, and virus-retentive filters for aseptic filling, bulk drug substance storage, and final formulation, aiming to reduce contamination risk and batch failures. The transition to personalized medicines, higher-value biologics, and complex combination products is escalating the need for reliable final product filtration, thereby giving final product filtration a prominent position as a major growth driver in the Europe pharmaceutical filtration market.
Germany accounted for the largest share of the Europe pharmaceutical filtration market in 2024.
The market for pharmaceutical filtration in Europe is segmented into Germany, the UK, France, Italy, Spain, Switzerland, and the Rest of Europe. Germany accounts for the largest share of the regional pharmaceutical filtration market, supported by its extensive biopharmaceutical manufacturing base, high healthcare expenditure, and strong emphasis on innovative biologics and advanced therapies. Dense clusters of CDMOs, research institutes, and large pharma companies in hubs drive intensive use of microfiltration, sterile filtration, and single-use systems across development and commercial production. Stringent EMA-aligned GMP frameworks, active investment incentives, and frequent technology upgrades further sustain demand for high-performance filtration solutions in Germany, reinforcing the country’s leadership within the European market.
Key players in the Europe pharmaceutical filtration market include Merck KGaA (Germany), Sartorius AG (Germany), Eaton Corporation Plc (Ireland), Porvair Plc (UK), Donaldson Company, Inc. (US), Alfa Laval Corporate AB (Sweden), and MMS AG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Pharmaceutical Filtration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
